The Journal of Organic Chemistry
Note
CDCl3) δ 62.2, 62.3, 66.4 (×2), 69.7 (×2), 69.9, 70.0, 71.6, 73.3, 97.6
(d, J = 174.9 Hz, Cα), 98.1 (d, J = 158.4 Hz, Cβ), 128.3 (×3), 128.4
(×3), 128.5 (×3), 128.6 (×6), 128.7 (×3), 128.8, 128.9, 129.1, 129.2,
129.3, 129.5, 129.8 (×3), 129.9 (×3), 130.0 (×6), 130.1, 130.2 (×3),
133.1 (×2), 133.3, 133.4, 133.5 (×2), 133.6, 133.7, 165.1, 165.2, 165.3,
165.4, 165.6, 165.7, 166.1 (×2). ESI-HRMS: 1192.3578 (M+NH4)+;
Anal. Calcd for C68H54O19 (1174.32): C, 69.50; H, 4.63; O, 25.87;
Found C, 69.61; H, 4.67.
75.3, 78.3, 98.9, 127.5 (×2), 127.6 (×2), 127.7 (×4), 128.0 (×2),
128.1 (×2), 128.4 (×3), 128.5 (×4), 130.0, 133.2, 138.1, 138.5 (×2),
165.8; API-ES positive 591.3 (M + Na)+. Anal. Calcd for C35H36O7
(568.24): C, 73.92; H, 6.38; O, 19.69. Found: C, 73.87; H, 6.30. Data
for 19b: 3.74−3.83 (m, 2H), 3.96 (m, 1H), 4.09−4.19 (m, 2H), 4.53
(d, J = 12.0 Hz, 1H), 4.55 (d, J = 12.0 Hz, 1H), 4.58 (d, J = 12.0 Hz,
1H), 4.67 (d, J = 12.0 Hz, 1H), 4.79 (d, J = 12.0 Hz, 1H), 4.88 (d, J =
12.0 Hz, 1H), 5.35 (bs, 1H), 5.63 (dd, J = 1.9, 3.0 Hz, 1H), 7.18−8.08
(m, 20H); 13C NMR (125 MHz, CDCl3) δ 69.8 (×2), 71.8, 71.9, 73.7,
74.9, 75.3, 77.9, 92.8, 127.7 (×3), 127.8 (×3), 128.1 (×3), 128.4 (×4),
128.5 (×4), 130.1 (×3), 133.2, 138.3, 138.6, 138.7, 165.9; API-ES
positive 573.6 (M + Na)+. Anal. Calcd for C34H34O7 (554.62): C,
73.63; H, 6.18; O, 20.19. Found: C, 73.51; H, 6.12.
Allyl 2,3,4,6-Tetra-O-benzoyl-α-D-mannopyranoside (20). Fol-
lowing the general procedure, 1,2-ortho ester 15 (63.6 mg, 0.1 mmol)
was treated with BF3·Et2O (38 μL, 0.3 mmol). After 10 min, Et3N
(42 μL, 0.3 mmol) was added and the resulting residue was con-
centrated and purified by flash chromatography (hexane/EtOAc 7/3) to
yield allyl glycoside 2049 (40 mg, 63%), hemiacetal 10 (5 mg, 8%), and
1α,1β′-disaccharide 8 (2 mg, 2%).
Reaction of Methyl Ortho Ester 4 with Different Acids. Reac-
tion with Yb(OTf)3. To a stirred solution of methyl ortho ester 4 (100 mg,
0.28 mmol) in anhydrous CH2Cl2 (4 mL), at room temperature, was
added Yb(OTf)3 (515 mg, 0.83 mmol). After 51/2 h all the starting
material has disappeared and the reaction mixture was treated with
Et3N (700 μL). The crude mixture was concentrated and purified by
flash chromatography (hexane/EtOAc 7/3) to yield hemiacetal 11
(87 mg, 91%).
Reaction with HgBr2. Methyl ortho ester 4 (100 mg, 0.28 mmol)
in anhydrous CH3CN (4 mL) at room temperature was treated with
HgBr2 (302.4 mg, 0.84 mmol). After 12 h, the reaction mixture was
diluted with CH2Cl2 and quenched by addition of saturated aqueous
NaHCO3. The layers were separated, the aqueous phase was extracted
with CH2Cl2, and the combined organic layers were washed with
saturated aqueous NaCl. The resultant organic phase was dried over
Na2SO4, filtered, and concentrated. The residue was purified by flash
silica gel column chromatography (hexane/EtOAc 7/3) to yield
hemiacetal 11 (41 mg, 42%).
(2,3,4,6-Tetra-O-benzoyl-α-D-mannopyranosyl)-2,3,4,6-tetra-O-
acetyl-α-D-mannopyranoside and (2,3,4,6-Tetra-O-benzoyl-α-D-
mannopyranosyl)-2,3,4,6-tetra-O-acetyl-β-D-mannopyranoside
(12). To a stirred solution of the 1,2-ortho ester 7 (91.6 mg,
0.15 mmol) and hemiacetal 1148 (52.2 mg, 0.15 mmol) was added
BF3·Et2O (57 μL, 0.45 mmol). After 5 min, Et3N (63 μL, 0.45 mmol)
was added and the resulting residue was purified by flash
chromatography (hexane/EtOAc, 8/2 to 7/3) to give 8 (34 mg,
38%) and 1,1′-disaccharides 12 (1α, 1′α/1α, 1′β; 3.2/1 ratio) (12.4 mg,
9%) along with other compounds such as 2,3,4,6-tetra-O-benzoyl-α-D-
mannopyranosyl fluoride (14 mg, 16%), methyl glycoside 9 (29 mg,
32%), and unchanged starting material 11 (30 mg, 57%). Selected data
for 12 are as follows. Major isomer: 1α,1′α-disaccharide 1H NMR
(500 MHz, CDCl3) δ 5.27 (d, J = 1.3 Hz, 1H, H-1′), 5.46 (dd, J = 1.3,
3.5 Hz, 1H, H-2′), 5.46 (d, J = 1.8 Hz, 1H, H-1), 5.72 (dd, J = 1.8,
3.4 Hz, 1H, H-2); 13C NMR (125 MHz, CDCl3) δ 93.17 (d, J = 173.8
Hz, C-1α), 93.49 (d, J = 173.3 Hz, C-1′α). Minor isomer: 1α,1′β-
1
disaccharide H NMR (500 MHz, CDCl3) δ 5.01 (d, J = 1.2 Hz, 1H,
H-1′), 5.38 (d, J = 1.8 Hz, 1H, H-1), 5.60 (dd, J = 1.2, 3.3 Hz, 1H, H-
2′), 5.64 (d, J = 1.8, 3.3 Hz, 1H, H-2); 13C NMR (125 MHz, CDCl3):
δ 97.84 (d, J = 156.7 Hz, C-1′β), 98.10 (d, J = 175.3 Hz, C-1α). Anal.
Calcd for C48H46O19 (926.86): C, 62.20; H, 5.00; O, 32.80. Found: C,
62.30; H, 5.10.
(2-O-acetyl-3,4,6-tetra-O-benzyl-α-D-mannopyranosyl)-2-O-
acetyl-3,4,6-tetra-O-benzyl-β-D-mannopyranoside (16). Following
the general procedure, the 1,2-ortho ester 13 (50.6 mg, 0.1 mmol) was
treated with BF3·Et2O (38 μL, 0.3 mmol). After 10 min, Et3N (42 μL,
0.3 mmol) was added, and the residue was purified by flash chromato-
graphy (hexane/EtOAc 8/2), to yield 1α,1β′-disaccharide 16 (11 mg,
23%) along with methyl glycoside 17a (32 mg, 64%) and hemiacetal
17b (6 mg, 11%). Data for 16: [α]D = +19.3° (c 0.14, CHCl3);
1H NMR (500 MHz, CDCl3) δ 2.06 (s, 3H), 2.07 (s, 3H), 3.38 (ddd,
J = 9.7, 4.3, 2.6 Hz, 1H), 3.52 (dd, J = 10.8, 1.9 Hz, 1H), 3.56 (dd, J =
9.3, 3.3 Hz, 1H), 3.58−3.68 (m, H), 3.86−3.92 (m, 2H), 3.99−4.02
(m, 1H), 4.25 (d, J = 12.1 Hz, 1H), 4.38 (d, J = 15.0 Hz, 1H), 4.39
(d, J = 15.0 Hz, 1H), 4.41 (d, J = 12.1 Hz, 1H), 4.43 (d, J = 15.0 Hz,
1H), 4.46 (d, J = 15.0 Hz, 1H), 4.49 (d, J = 15.0 Hz, 1H), 4.50 (d, J =
15.0 Hz, 1H), 4.61 (d, J = 11.4 Hz, 1H), 4.63 (d, J = 1.0 Hz, 1H), 4.67
(d, J = 11.4 Hz, 1H), 4.78 (d, J = 10.8 Hz, 1H), 4.79 (d, J = 10.8 Hz,
1H), 5.04 (d, J = 1.8 Hz, 1H), 5.23 (dd, J = 1.9, 2.9 Hz, 1H), 5.53 (dd,
J = 1.0, 3.2 Hz, 1H), 7.08−7.25 (m, 30H); 13C NMR (125 MHz,
CDCl3) δ 21.2, 21.5, 68.0, 68.5, 68.7, 69.3, 71.7, 72.0, 72.4, 73.4, 73.5,
74.1, 74.2, 75.2, 75.3, 75.9, 77.8, 80.2, 98.2, 98.3, 127.6 (x2), 127.7
(×2), 127.8 (×3), 127.9 (×3), 128.0 (×3), 128.2 (×3), 128.3 (×2),
128.4 (×4), 128.5 (×4), 128.6 (×4), 137.6, 138.0, 138.3, 138.4, 138.5,
138.7, 170.5, 170.6; ESI-HRMS 989.4203 (M + Na)+. Anal. Calcd for
C58H62O13 (966.4190): C, 72.03; H, 6.46; O, 21.51. Found: C, 72.25;
H, 6.33.
Methyl 2-O-Benzoyl-3,4,6-tetra-O-benzyl-α-D-mannopyranoside
(19a) and 2-O-Benzoyl-3,4,6-tetra-O-benzyl-α-D-mannose (19b). Fol-
lowing the general procedure, the 1,2-ortho ester 14 (56.8 mg,
0.1 mmol) was treated with BF3·Et2O (38 μL, 0.3 mmol). After 10 min
Et3N (42 μL, 0.3 mmol) was added and the resulting residue was
concentrated and purified by flash chromatography (hexane/EtOAc
7/3) to yield methyl glycoside 19a (29 mg, 51%) and hemiacetal 19b
(17 mg, 30%). Data for 19a: [α]D = +1.9° (c 0.58, CHCl3); 1H NMR
(500 MHz, CDCl3) δ 3.32 (s, 3H), 3.71 (dd, J = 1.5, 10.2 Hz, 1H),
3.76 (m, 1H), 3.81 (m, 1H), 3.99 (m, 2H), 4.46 (d, J = 10.9 Hz, 1H),
4.47 (d, J = 11.4 Hz, 1H), 4.48 (d, J = 11.4 Hz, 1H), 4.66 (d, J =
12.0 Hz, 1H), 4.70 (d, J = 12.0 Hz, 1H), 4.78 (d, J = 2.2 Hz, 1H), 4.80
(d, J = 10.2 Hz, 1H), 5.54 (bt, J = 2.2 Hz, 1H), 7.10−8.01 (m, 20H);
13C NMR (125 MHz, CDCl3) δ: 55.1, 69.0, 69.2, 71.5, 71.6, 73.5, 74.4,
Reaction with AW-300. A solution of methyl ortho ester 4 (50 mg,
0.14 mmol) in anhydrous CH2Cl2 (4 mL) was treated with acid
molecular sieves AW-300 (1.6 mm pellets, 1 g). After it was heated for
2 h at 50 °C under MW irradiation, the crude mixture was filtered and
the solvent was removed under reduced pressure. The residue was
purified by flash silica gel column chromatography (hexane/EtOAc
7/3) to afford methyl glycoside 6 (46 mg, 90%).
Reaction with TMSOTf. To a stirred solution of methyl ortho ester
4 (100 mg, 0.28 mmol) in anhydrous CH2Cl2 (4 mL) at −30 °C was
added TMSOTf (158 μL, 0.84 mmol). After 5 min, the reaction
mixture was diluted with CH2Cl2 and quenched by addition of
saturated aqueous NaHCO3. The layers were separated, the aqueous
phase was extracted with CH2Cl2, and the combined organic layers
were washed with saturated aqueous NaCl. The resultant organic
phase was dried over Na2SO4, filtered, and concentrated.
The resulting residue was purified by silica gel flash column
chromatography (hexane/EtOAc, 1/1) to yield methyl glycoside 6
(4.6 mg, 4.5%), methyl 3,4,6-tri-O-acetyl-2-O-(2,3,4,6-tetra-O-acetyl-α-
D-mannopyranosyl)-mannopyranoside 2150 (42.4 mg, 46%), and
trisaccharide 22 (19 mg, 21%). Data for 22: [α]D = +2.0° (c 0.64,
1
CHCl3); H NMR (500 MHz, CDCl3) δ 2.00 (s, 3H), 2.02 (s, 3H),
2.03 (s, 6H), 2.05 (s, 3H), 2.06 (s, 3H), 2.08 (s, 3H), 2.12 (s, 3H),
2.13 (s, 3H), 2.15 (s, 3H), 3.41 (s, 3H), 3.89 (m, 1H), 4.01 (m, 1H),
4.06−4.19 (m, 8H), 4.23 (dd, J = 4.8, 12.0 Hz, 1H), 4.86 (bs, 1H),
4.94 (bs, 1H), 5.09 (d, J = 1.6 Hz, 1H), 5.24−5.32 (m, 6H), 5.38 (dd,
J = 3.2, 10.0 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ: 20.8 (×4),
20.9 (×4), 21.0 (×2), 55.4, 62.3, 62.4, 62.7, 66.3, 66.4, 68.5, 68.6, 69.4,
69.6, 69.7, 69.8, 70.5, 76.7, 77.4, 99.3, 99.5, 99.9, 169.5, 169.6 (×2),
169.8, 169.9, 170.2, 170.3, 170.6, 170.9, 171.0; ESI-HRMS 956.3215
(M + NH4)+. Anal. Calcd for C39H54O26 (938.8305): C, 49.89; H,
5.80; O, 44.31. Found: C, 49.71; H, 5.77.
798
dx.doi.org/10.1021/jo202335n | J. Org. Chem. 2012, 77, 795−800